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PROTEINASES AND THEIR INHIBITORS IN SEPTICEMIA 
- BASIC CONCEPTS AND CLINICAL IMPLICATIONS 
M. Jochum 2, K.-H. Duswald 1, S. Neumann3, 
J. W i t t e 1 , H. F r i t z 2 
1 S u r g i c a l C l i n i c , department of C l i n i c a l 
Chemistry & Biochemistry, U n i v e r s i t y of 
Munich, ^Department of Biochemical Research 
E. Merck, Darmstadt, FRG 
INTRODUCTION 
The Role of Lysosomal Enzymes i n Inflammation 
During the inflammatory response various systemic 
or l o c a l t i s s u e c e l l s are a c t i v a t e d thereby r e l e a s i n g 
i n t e r n a l , mostly lysosomal enzymes. They t r i g g e r the ac-
t i v a t i o n of the c l o t t i n g , f i b r i n o l y s i s and complement 
cascades, the di s r u p t u r e of c e l l membranes and t i s s u e 





(j© ^ \ - m Endotoxins 
O) ^ ^ r ~ \ \ (endogenous & exogenous) 
( * 1 ) 
\. Antigen-antibody complexes 




toxic peptides: blood pressure J, edema, heart toxic, clotting inh. * 
degradation/inactivation: membranes, connective tissue, plasma factors < 
activ. of system-specific proteases: thrombin, plasmin, C1-esterase, kallikrein ' 
Fig. 1: L i b e r a t i o n and e f f e c t s of lysosomal f a c -
t o r s . For d e t a i l s see t e x t . 
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Phagocytes, e s p e c i a l l y the granulocytes and mono-
cytes or macrophages, but also f i b r o b l a s t s , e n d o t h e l i a l 
c e l l s and mast c e l l s are known t o be very r i c h i n such 
i n t e r n a l or lysosomal enzymes. 
So f a r , only the p r o p e r t i e s and pathobiochemical 
e f f e c t s of enzymes of the a z u r o p h i l i c and s p e c i f i c l y -
sosomes of polymorphonuclear granulocytes (neutrophils) 
have been i n v e s t i g a t e d i n more d e t a i l . Such enzymes, f o r 
example the n e u t r a l elastase and cathepsin G as w e l l as 
the a c i d i c cathepsins are preformed and stored i n the 
lysosomes i n f u l l y a c t i v e form1/2. i n t h i s way, they can respond immediately t o perform t h e i r b i o l o g i c a l f u n c t i o n , 
namely the degradation of e x t r a c e l l u l a r and i n t r a c e l l u -
l a r m a t e r i a l a f t e r phagocytosis. 
Outside the phagocytes, p r o t e o l y t i c a c t i o n of the 
lysosomal enzymes i s normally prevented or balanced by 
proteinase i n h i b i t o r s present i n plasma, i n t e r s t i t i a l 
f l u i d and body secretions (Fig. 2). These i n h i b i t o r s 
M.W. Mean cone. 
Abbr. Inhibitor x 1 000 rog/KX) ml 
Oc^ ö^-Macroglobulin 725 260 3.6 
(XpProtease inhibitor 50 260 52 
CX-jAC OcpAntichymotrypsin 70 45 6.4 
ß-j-Collagenase inn. 40 1.5 0.4 
ITI Inter-Oc-trypsin inh. 160 45 2.8 
AT III Antithrombin III 65 26 4.0 
a
2
PI 0c2-Plasmin inhibitor 70 6 0.9 
C1 INA C1-lnactivator 100 24 2.4 
Fig. 2: Plasma i n h i b i t o r s d i r e c t e d against l y s o -
somal proteinases of various body c e l l s 
or plasma-derived proteinases. 
comprise together w i t h i n h i b i t o r s of c l o t t i n g , f i b r i n o -
l y s i s and complement proteinases more than 10 % of the 
plasma p r o t e i n s . Non-lysosomal proteinases l i k e , f o r 
example, thrombokinases and plasminogen a c t i v a t o r s are 
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faced only w i t h a very low i n h i b i t o r y p o t e n t i a l i n body 
f l u i d s . They are, t h e r e f o r e , p r i v i l e g e d candidates f o r 
the a c t i v a t i o n of c l o t t i n g and f i b r i n o l y s i s i f released 
i n t o the c i r c u l a t i o n a f t e r increased production due t o 
an inflammatory stimulus. 
Endotoxins: cell membrane damage —proteinase liberation 
1 — i 
Thrombokinase 
Plasmin activator 
j Specific activation 
of blood systems 
~- Granulocytic elastase; 
** cathepsins G; B, H, L; D i 
Unspecific degradation 
o clotting 
°fibrinolysis (FOP •) 
°complement (C3a •) 
°kallikrein (kinin •) 
cells: platelets, pha-
gocytes, mast cells 






J ß XI i 
- i - i J — i 
tion 




°tissue substances etc. 
phagocyte/lymphocyte 
activation 
! Elimination of enzyme-inhibitor complexes by RES ! 
i i 
Fig. 3: Consumption of plasma f a c t o r s during i n -
flammation. For d e t a i l s see t e x t . 
Abbreviations: antithrombin I I I (AT I I I ) , a 2 - p l a s -min i n h i b i t o r (c^PI)/ C1 i n a c t i v a t o r (C1 INA), a-|-
proteinase i n h i b i t o r (a^PI, formerly a-|-antitryp-
sin) , (*2 -macroglobulin (ct2M), a-]-antichymotrypsin 
(a-jAC) , ß-j -collagenase i n h i b i t o r (ß<|CI), f i b r i n 
(-ogen) degradation products (FDP), complement fac-
t o r (C 3a), r e t i c u l o e n d o t h e l i a l system (RES). 
Lysosomal enzymes l i b e r a t e d during severe i n f l a m -
mation l i k e septicemia or septic shock can enhance, t o -
gether w i t h thrombokinases and plasminogen a c t i v a t o r s , 
the inflammatory response v i a two major routes charac-
t e r i z e d by e i t h e r s u b s t r a t e - s p e c i f i c or substrate-un-
s p e c i f i c p r o t e o l y s i s (Fig. 3 ). 
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The system-specific proteinases, thrombokinases and 
plasminogen a c t i v a t o r s , t r i g g e r the a c t i v a t i o n of the 
c l o t t i n g , f i b r i n o l y s i s and complement cascades (summa-
r i z e d as 'blood systems') by s u b s t r a t e - s p e c i f i c proteo-
l y s i s of proenzymes and cofactors. The a c t i v a t e d enzymes 
are subsequently i n h i b i t e d by t h e i r n a t u r a l i n h i b i t o r s ; 
the enzyme-inhibitor complexes thus formed are r a p i d l y 
eliminated from the c i r c u l a t i o n by the reticuloendo-
t h e l i a l system (RES). Hence, i n a series of steps based 
on h i g h l y s p e c i f i c i n t e r a c t i o n s not only the proteinases 
r e s p e c t i v e l y t h e i r zymogens are consumed but also t h e i r 
n a t u r a l antagonists, the system-specific i n h i b i t o r s . Un-
t i l r e c e n t l y , the given sequence of reactions was as-
sumed t o be e x c l u s i v e l y responsible f o r the development 
of disseminated i n t r a v a s c u l a r coagulation ( D I C ) . 
Results obtained very r e c e n t l y i n d i c a t e t h a t an 
a d d i t i o n a l r e a c t i o n path may c o n t r i b u t e considerably t o 
the consumption of plasma f a c t o r s during severe i n f l a m -
mations. This implies i n a c t i v a t i o n of plasma f a c t o r s by 
substrate-unspecific p r o t e o l y s i s due t o l i b e r a t e d l y s o -
somal proteinases. Egbring and coworkers observed i n 
animals a s i g n i f i c a n t decrease i n several c l o t t i n g fac-
t o r s a f t e r i n f u s i o n of endotoxin or human n e u t r o p h i l 
elastase^. S i m i l a r r e s u l t s were obtained by Ohlsson and 
coworkers^/5 i n canine endotoxemia. Moreover, i n p a t i e n t s 
s u f f e r i n g from sepsis or septic shock a s t r i k i n g consump-
t i o n of blood system f a c t o r s , immunoglobulins and pro-
teinase i n h i b i t o r s has been found by the teams of Eg-
bringG, Aasen^, GallimoreS and Witte^. 
The potency of lysosomal enzymes f o r the degrada-
t i o n of n a t i v e plasma p r o t e i n i n h i b i t o r s was also de-
monstrated i n v i t r o by the i n a c t i v a t i o n of antithrombin 
I I I due to c a t a l y t i c amounts of n e u t r o p h i l elastase" 1 0. 
on-Protease i n h i b i t o r (formerly a-]-antitrypsin) i s inac-
t i v a t e d i n a s i m i l a r way by the macrophage e l a s t a s e l l 
and, i n a d d i t i o n , by o x i d a t i o n of i t s r e a c t i v e - s i t e me-
t h i o n i n e residue v i a the lysosomal myeloperoxidase/hyd-
rogen peroxide system^. 
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RESULTS 
Neutrophil Elastase and Plasma Factors i n Sepsis 
Assay of l i b e r a t e d elastase. Due t o the presence of 
an excess of the endogenous i n h i b i t o r s a 1-protease i n h i -
b i t o r (a-|PI) and a2-macroglobulin (ot2M) , d i r e c t measure-
ment of the n e u t r o p h i l - d e r i v e d proteinase a c t i v i t i e s i n 
plasma or other body f l u i d s i s not f e a s i b l e . However, 
increased l e v e l s of the elastase-ot-jPI complex would be 
already a clear i n d i c a t i o n f o r elastase l i b e r a t i o n . 
Q u a n t i t a t i v e estimation of the plasma l e v e l s of the e l a -
stase-a-j-protease i n h i b i t o r complex was c a r r i e d out w i t h 
a h i g h l y s e n s i t i v e enzyme-linked immunoassay^. B r i e f l y , 
the E-a-jPI complex of the plasma sample was bound t o 
s u r f a c e - f i x e d antibodies d i r e c t e d against n e u t r o p h i l 
elastase. A f t e r washing, a second a l k a l i n e phosphatase-
l a b e l l e d antibody d i r e c t e d against a-|PI was f i x e d t o 
the complex. Under s u i t a b l e c o n d i t i o n s , the a c t i v i t y of 
f i x e d a l k a l i n e phosphatase towards p-nitrophenylphos-
phate i s p r o p o r t i o n a l t o the concentration of the E-a-|PI 
complex i n the sample. 
I n a f i r s t approach, we were i n t e r e s t e d t o see 
whether a r e l a t i o n s h i p e x i s t s between the plasma l e v e l s 
of E-a-|PI and the s e v e r i t y of postoperative i n f e c t i o n s . 
To achieve t h i s purpose, besides other f a c t o r s the l e v -
els of f a c t o r X I I I (Faktor X l l l - S c h n e l l t e s t , Behring-
werke AG Marburg) and antithrombin I I I (S-2238, Deutsche 
Kabi Munich) were continuously monitored because both 
c l o t t i n g f a c t o r s are known t o be e a s i l y degraded by 
n e u t r o p h i l elastase i n v i t r o . 
Patients. I n the c l i n i c a l t r i a l , p a t i e n t s subjec-
ted t o major abdominal surgery were included i f the ope-
r a t i o n time exceeded 120 min. Diagnosis of septicemia i n 
the postoperative course was confirmed by prospectively 
established septic c r i t e r i a . I n the prospective study 
more than 120 p a t i e n t s were included. T h i r t y of them 
f u l f i l l e d the defined septic c r i t e r i a during the post-
operative course. Of these p a t i e n t s , fourteen survived 
the i n f e c t i o n (group B) whereas sixteen died as a d i r e c t 
r e s u l t of septicemia (group B). Eleven p a t i e n t s being 
without i n f e c t i o n a f t e r abdominal surgery served as con-
t r o l s (group A) (Fig. 4). 
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o Defined infection site & pos. bact. culture 
^ Body temperature > 38.5°C 
" Leukocytosis with > 15 000 cells/mm or 
o 
Leukocytopenia with < 5 000 ce11s/mm° 
° Platelets -= 100 000/mm
3
 or drop - 30 % 
o (Positive blood culture) 
Fig. 4: Prospectively defined sepsis c r i t e r i a . 
Diagnosis of septicemia i n the postoperative 
course was confirmed i n p a t i e n t s f u l f i l l i n g 
a l l these conditions. 
Elastase-a 1PI l e v e l s . With the enzyme-linked immu-noassay elastase l e v e l s between 60 and 110 ng/ml were 
found i n 153 healthy i n d i v i d u a l s . I n p a t i e n t s without 
preoperative i n f e c t i o n (group A and B), the operative 
trauma was followed by an increase of the E-a-jPI l e v e l 
up to 3-fold of the normal value. Patients s u f f e r i n g 
from preoperative i n f e c t i o n s (6 out of 16 i n group C) 
showed already c l e a r l y elevated preoperative E-oc|PI l e v -
e l s . Immediately a f t e r surgery a s l i g h t decrease was ob-
served, probably due t o e l i m i n a t i o n of the i n f e c t i o n f o -
cus. Before onset of sepsis, the E-aqPI concentrations 
of group B and C showed a moderate e l e v a t i o n but no s i g -
n i f i c a n t changes compared to the postoperative l e v e l s . 
However, at the beginning of septicemia a h i g h l y s i g n i -
f i c a n t increase of the E-a-jPI l e v e l s could be detected: 
up t o 6-fold i n group B and up to 10-fold i n group C 
Peak l e v e l s were found above 2 500 ng/ml i n both groups. 
The E-a-jPI l e v e l s of septic p a t i e n t s who recovered showed 
a cl e a r tendency towards normal values. I n p a t i e n t s w i t h 
p e r s i s t i n g septicemia, high l e v e l s of E-a-jPI were meas-
ured u n t i l death. (Fig. 5 ) . 




E-a^PI ( N W = 6 0 - 1 1 0 ) 
100 1 
vor Op. nach Op. 
n.s. 
p < 0 . 0 2 5 
p < 0 . 0 2 5 
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p < 0 . 0 0 0 5 
p < 0 . 0 0 0 5 
p « 0 . 0 1 2 5 
Beginn 
d. Sepsis 
Verlauf E G T 
p < 0 . 0 0 2 5 n.s. 
p < 0 . 0 0 0 5 p < 0.012 
p < 0 . 0 0 0 5 P < 0.0125 
Fig. 5: Plasma l e v e l s of elastase-a^-proteinase 
i n h i b i t o r complex (E-a-|PI) i n p a t i e n t s subjected 
t o major abdominal surgery. 
A = p a t i e n t s (n=11) being without postoperative 
i n f e c t i o n 
B = p a t i e n t s (n=14) s u r v i v i n g postoperative sep-
ticemia 
C = p a t i e n t s (n=16) dying as a r e s u l t of s e p t i -
cemia 
The E-a-jPI l e v e l s are given as mean values (_+ SEM) 
f o r the day before operation, the day a f t e r opera-
t i o n as w e l l as f o r the postoperative phase before 
sepsis, at onset of sepsis and during septicemia. 
Last determinations were done on day of discharge 
(D) f o r group A, on day of recovery (R) f o r group 
B, and before death (D o r t ) f o r group C. 
nr = normal range. 
Antithrombin I I I a c t i v i t y . I n non-infected p a t i e n t s 
the a c t i v i t y of AT I I I , the most important i n h i b i t o r of 
the c l o t t i n g system, was i n the normal range during the 
whole observation period. I n i n f e c t e d p a t i e n t s , however, 
the AT I I I a c t i v i t y was found already below the c l i n i -
c a l l y c r i t i c a l concentration of about 75 % of the stand-
ard mean value before onset of septicemia. This low v a l -
ue normalized i n a l l p a t i e n t s overcoming the i n f e c t i o n , 
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whereas a f u r t h e r s i g n i f i c a n t decrease (up t o 45 % of 
the norm) was found i n group C p a t i e n t s w i t h l e t h a l out-
come. Probably, the extremely low AT I I I a c t i v i t y i n the 
l a t t e r p a t i e n t s , having permanently elevated E-a-jPI l e v -
e l s , may be due to a s i g n i f i c a n t degree to degradation 
by lysosomal enzymes and e s p e c i a l l y by elastase. 
before op after op course onset during D R t 
after op of sepsts sepsis 
Fig. 6: Plasma l e v e l s of the i n h i b i t o r y a c t i -
v i t y of antithrombin I I I (AT I I I ) compared t o 
the amount of the elastase-a-j-proteinase i n h i -
b i t o r complex (E-a-jPI) i n p a t i e n t s subjected 
to major abdominal surgery. 
For d e t a i l s , see legend to Fig. 5 
Factor X I I I a c t i v i t y and A & S subunit l e v e l s . S i -
m i l a r r e s u l t s were obtained f o r F X I I I , the f i b r i n sta-
b i l i z i n g coagulation f a c t o r . I n plasma of p a t i e n t s who 
did not survive septicemia, the F X I I I a c t i v i t y decreased 
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up to 28 % of the standard mean value. As measured by 
Immunoelectrophoresis, these p a t i e n t s also had very low 
concentrations of both subunit A, comprising the a c t i v e 
enzyme, and subunit S, representing the c a r r i e r p r o t e i n 
(data not shown). I n c o n t r a s t , group A p a t i e n t s w i t h un-
complicated postoperative course showed normal or only 
s l i g h t l y decreased concentrations of subunit S, although 
subunit A and f i b r i n s t a b i l i z i n g a c t i v i t i e s were o f t e n 
s i g n i f i c a n t l y reduced. 
Fig. 7: Plasma l e v e l s of the f i b r i n s t a b i l i z i n g 
a c t i v i t y of f a c t o r X I I I (F X I I I ) compared t o 
the amount of the elastase-a-^-proteinase i n h i b i -
t o r complex (E-a-|PI) i n p a t i e n t s subjected t o 
major abdominal surgery. 
For d e t a i l s , see legend t o Fig. 5 
As demonstrated formerly by Egbring and coworkers and 
Ikematsu and coworkers^, reduction of both subunits of 
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F X I I I cannot be due t o a c t i v a t i o n of the c l o t t i n g cas-
cade alone. During c l o t t i n g , t h a t means by the a c t i o n of 
thrombin only subunit A i s consumed simultaneously w i t h 
the F X I I I a c t i v i t y but not subunit S. Elastase, however, 
i s able t o degrade both subunits t o a s i m i l a r degree. 
These data and the r e s u l t s presented i n our c l i n i c a l 
t r a i l suggest t h a t i n the p a t i e n t s s u f f e r i n g from s e p t i -
cemia, unspecific p r o t e o l y t i c degradation by granulocy-
t i c elastase and/or other lysosomal proteinases i s i n -
volved t o a s i g n i f i c a n t degree i n the d e p l e t i o n of F X I I I . 
Conclusions from the C l i n i c a l Studies. The r e s u l t s 
of the c l i n i c a l studies show t h a t i n inflammatory d i s -
eases a c o r r e l a t i o n e x i s t s between the release of a l y -
sosomal enzyme marker, the n e u t r o p h i l elastase, and the 
c l i n i c a l s i t u a t i o n of the p a t i e n t r e s p e c t i v e l y the con-
sumption of selected plasma f a c t o r s . We take t h i s as a 
c l e a r i n d i c a t i o n t h a t l i b e r a t e d lysosomal f a c t o r s and 
e s p e c i a l l y n e u t r o p h i l proteinases c o n t r i b u t e s i g n i f i -
c a n t l y t o the inflammatory response of the organism by 
substrate-u n s p e c i f i c degradation of plasma and 
other f a c t o r s . Early a p p l i c a t i o n of s u i t a b l e and potent 
exogenous proteinase i n h i b i t o r s should prevent or at 
l e a s t diminish, t h e r e f o r e , such d e s t r u c t i v e p r o t e o l y t i c 
processes. 
I n h i b i t o r therapy i n experimental endotoxemia 
To confirm t h i s assumption, we established an endo-
toxemia model i n dogs by intravenous i n f u s i o n of E. c o l i 
endotoxin f o r 2 hours. Thereby, a s i g n i f i c a n t decrease 
was observed i n the plasma l e v e l s of the c l o t t i n g f a c -
t o r s antithrombin I I I , prothrombin and f a c t o r X I I I , of 
the f i b r i n o l y s i s f a c t o r s plasminogen and ot2 -antiplasmin, 
and of the complement f a c t o r C3. The l e v e l s were followed 
up over an experimental period of fourteen hours and ^ ^  
t h e i r a l t e r a t i o n s checked f o r s t a t i s t i c a l s i g n i f i c a n c e 
(Fig. 8). 
Simultaneous intravenous a d m i n i s t r a t i o n of a r e l a -
t i v e l y s p e c i f i c i n h i b i t o r of n e u t r o p h i l elastase and 
cathepsin G, the Bowman-Birk i n h i b i t o r from soybeans, 
c l e a r l y reduced the endotoxin-induced decline of the 
tested plasma f a c t o r s . The 7 000 dalton i n h i b i t o r y m i n i -
p r o t e i n was e f f e c t i v e i n dosages ranging from 3 - 8 mg 
( i . e . 10 - 25 t r y p s i n i n h i b i t i n g u n i t s ) per kilogram 
body weight. A reasonable assumption would be, t h e r e -
f o r e , t h a t the endogenous i n h i b i t o r was able t o prevent 
or reduce the n e u t r o p h i l proteinase-induced consumption 
reactions very e f f e c t i v e l y . 
F i g . 8: Changes i n the plasma l e v e l s of various plasma f a c t o r s during the 
acute phase of experimental end'otoxemia i n dogs (n=6 f o r each group) w i t h -
out or w i t h i n h i b i t o r treatment. Applied i n h i b i t o r dosages: 1 0 - 2 5 t r y p s i n 
i n h i b i t i n g u n i t s (Bowman Bi r k i n h i b i t o r ) or 80 000 k a l l i k r e i n i n h i b i t o r 
u n i t s ( a p r o t i n i n ) per kg body weight over the observation period of 14 hours. 
Data are given as mean values i n percentage of the i n d i v i d u a l s t a r t i n g values. 
Thick l i n e a t the abscissa = endotoxin i n f u s i o n period. For f u r t h e r d e t a i l s 
see t e x t and r e f . 15. 
o 
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S u r p r i s i n g l y , intravenous a d m i n i s t r a t i o n of the 
broad-spectrum proteinase i n h i b i t o r a p r o t i n i n (Trasylol) 
reduced the endotoxin-induced reduction of the plasma 
fa c t o r s t o a s i m i l a r degree (Fig. 8 ) . We must emphasize, 
however, t h a t the administered a p r o t i n i n dose of 80 000 
k a l l i k r e i n i n h i b i t o r u n i t s ( i . e . 9.6 mg of the basic 
6 500 dalton m i n i p r o t e i n from bovine organs) per k i l o -
gram body weight over the observation period of 14 hours 
would correspond t o 5.6 M i l l , k a l l i k r e i n i n h i b i t i n g u n i t s 
i n the case of a 70 kg p a t i e n t or to 9.6 M i l l KIU/24 h. 
Although we do not know at present the lowest dosage of 
a p r o t i n i n e f f e c t i v e i n our animal model, we speculate 
t h a t a r e l a t i v e l y high dose i s necessary t o i n h i b i t ef-
f e c t i v e l y endotoxin-induced a c t i v a t i o n of the i n t r i n s i c 
c l o t t i n g cascade and thus also systemic f i b r i n o l y s i s as 
w e l l as complement react i o n s . 
GENERAL CONCLUSIONS 
In severe inflammatory processes, m u l t i p l e trauma 
or shock various c e l l s l i k e n e u t r o p h i l s , macrophages, 
e n d o t h e l i a l c e l l s , and mast c e l l s are stimulated or des-
i n t e g r a t e d . I n t h i s way a high p o t e n t i a l of lysosomal 
enzymes i s released of which the proteinases are of spe-
c i a l pathogenetic e f f e c t i v e n e s s . Recent studies i n our 
laboratory and by others i n d i c a t e s t r o n g l y t h a t substra-
t e -unspecific p r o t e o l y s i s by lysosomal proteinases and 
esp e c i a l l y by the n e u t r o p h i l elastase c o n t r i b u t e s t o a 
s i g n i f i c a n t degree t o the consumption and/or degradation 
of e x t r a c e l l u l a r substances i n such diseases. On the 
other hand, e a r l y a d m i n i s t r a t i o n of convenient exogenous 
i n h i b i t o r s d i r e c t e d against the lysosomal enzymes and/or 
plasmin should have a p o s i t i v e therapeutic e f f e c t also 
i n humans. 
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